Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
- Klaus F. Rabe*
- , Henrik Watz
- , Simonetta Baraldo
- , Frauke Pedersen
- , Davide Biondini
- , Nitin Bagul
- , Guido Hanauer
- , Udo Michael Göhring
- , Debasree Purkayastha
- , Jonas Román
- , Vijay K.T. Alagappan
- , Marina Saetta
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
53
Citations
(Scopus)